"Tumors of the Central Nervous System: Primary and Secondary" ed. by Lee Roy Morgan

A novel concept that is reviewed and discussed in several chapters in the book alludes to the transport of drugs bound to red blood cells into the highly vascular CNS tumors - both primary and metastatic.

It is hopeful that the novel information presented in this book will result in new approaches to the treatment CNS tumors.

Contents
Preface
1 High Grade Glioma — Standard Approach, Obstacles and Future Directions
2 Paediatric Brainstem Cancers — Where We Have Been; Where We Are; Where We Are Going
3 Spatial Relationships of MR Imaging and Positron Emission Tomography with Phenotype, Genotype and Tumor Stem Cell Generation in Glioblastoma Multifbrme
4 New Application of 1231-Iodoamphetamine SPECT for the Diagnosis of Primary Central Nervous System Lymphoma
5 Biochemical and Surgical Aspects of Epilepsy Related to Brain Tumors — Appraising Redox Biology and Treatments
6 Alterations in TP53 gene - Implications in Tumorigenesis Process and Prognosis in Central Nervous System Cancer
7 Anti-Angiogenesis, Gene Therapy, and Immunotherapy in Malignant Gliomas
8 Erlotinib in Glioblastoma - A Current Clinical Perspective
9 Comparative Preclinical Pharmacology and Toxicology for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) — A Potential Neuro-Alkylating Agent for Glioblastoma (GBM) and Metastatic Cancers Involving the Central Nervous System